December 11, 2006 — The US Food and Drug Administration (FDA) and Baxter Healthcare Corp have warned healthcare professionals regarding the risk for delayed-onset heparin-induced thrombocytopenia (HIT ...

Patients with ST-segment elevation myocardial infarction (STEMI) who receive early emergency heparin can be safely switched to bivalirudin before undergoing percutaneous coronary intervention (PCI).

Since the treatment of disseminated intravascular coagulation consists of delaying the coagulation cascade by using low doses of anticoagulants, a group of authors from Sirio-Libanes Hospital in São ...

Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the anti-Xa less ...

Dallas, TX - A lot has happened in the field of anticoagulant therapy since the American Heart Association (AHA) last released a statement on the use of heparin in 1994. A new scientific statement, ...

THE chief obstacles to the wide-scale use of heparin in the treatment of venous thromboembolic disease, are two: the expense of the available commercial heparin preparations and the transiency of ...

Heparin-induced thrombocytopenia (HIT) can be a serious complication of unfractionated heparin therapy. There are two types of HIT: Type I HIT: This form is non-immune mediated. Thrombocytopenia (low ...

A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein ...

Viral vector gene delivery and the field of gene therapy have evolved tremendously over the past decade. The use of vectors derived from viruses is transitioning from the bench to the clinic and may ...

Heparin is widely used as an anticoagulant, but evokes in some patients a potentially life-threatening condition called HIT. Clinical scientists at Ludwig-Maximilians-Universitaet (LMU) in Munich have ...

Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the anti-Xa less ...